KEGG   DRUG: Insulin injection, biphasic isophaneHelp
Entry
D08080                      Drug                                   

Name
Insulin injection, biphasic isophane (BAN);
Insulin Humacart (TN)
Class
Antidiabetic agent
 DG01636  Insulin and analogue
  DG01802  Human insulin
Cyp inducer
 DG01637  CYP1A2 inducer
Activity
Antidiabetic, Insulin receptor agonist
Comment
Insulin with both rapid and intermediate action
Target
INSR (CD220) [HSA:3643] [KO:K04527]
  Pathway
Adherens junction
Insulin signaling pathway
Type II diabetes mellitus
Aldosterone-regulated sodium reabsorption
Interaction
CYP induction: CYP1A2 [HSA:1544]
Drug interaction
Brite
Target-based classification of drugs [BR:br08310]
 Cytokine receptors
  Receptor tyrosine kinase
   RTK class II (Insulin receptor family)
    insulin receptor
     Isophane insulin
      D08080  Insulin injection, biphasic isophane (BAN)
Cytochrome P450 interactions [BR:br08309]
 CYP inducers
  CYP1A2
   Insulin
    D08080  Insulin injection, biphasic isophane (BAN)
BRITE hierarchy
Other DBs
CAS: 
8063-29-4
PubChem: 

» Japanese version   » Back

DBGET integrated database retrieval system